328 related articles for article (PubMed ID: 21523764)
41. Expression of the repressor element-1 silencing transcription factor (REST) is influenced by insulin-like growth factor-I in differentiating human neuroblastoma cells.
Di Toro R; Baiula M; Spampinato S
Eur J Neurosci; 2005 Jan; 21(1):46-58. PubMed ID: 15654842
[TBL] [Abstract][Full Text] [Related]
42. β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H.
Cheng Y; Gao WW; Tang HM; Deng JJ; Wong CM; Chan CP; Jin DY
Sci Rep; 2016 Mar; 6():23938. PubMed ID: 27029215
[TBL] [Abstract][Full Text] [Related]
43. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
[TBL] [Abstract][Full Text] [Related]
44. Differential effects of retinoic acid isomers on the expression of nuclear receptor co-regulators in neuroblastoma.
Lovat PE; Annicchiarico-Petruzzelli M; Corazzari M; Dobson MG; Malcolm AJ; Pearson AD; Melino G; Redfern CP
FEBS Lett; 1999 Feb; 445(2-3):415-9. PubMed ID: 10094499
[TBL] [Abstract][Full Text] [Related]
45. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.
Wainwright LJ; Lasorella A; Iavarone A
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9396-400. PubMed ID: 11481496
[TBL] [Abstract][Full Text] [Related]
46. CENP-W inhibits CDC25A degradation by destabilizing the SCF
Cheon Y; Lee S
FASEB J; 2018 Jun; ():fj201701358RRR. PubMed ID: 29863914
[TBL] [Abstract][Full Text] [Related]
47. DR-nm23 gene expression in neuroblastoma cells: relationship to integrin expression, adhesion characteristics, and differentiation.
Amendola R; Martinez R; Negroni A; Venturelli D; Tanno B; Calabretta B; Raschellà G
J Natl Cancer Inst; 1997 Sep; 89(17):1300-10. PubMed ID: 9293921
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of β-transducin repeat-containing protein ligands screened using a high-throughput screening system.
Liu X; Sanada E; Li J; Li X; Osada H; Watanabe N
Oncol Res; 2023; 31(5):645-654. PubMed ID: 37547765
[TBL] [Abstract][Full Text] [Related]
49. The extracellular signal-regulated kinase-mitogen-activated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-TrCP-dependent degradation for cell cycle arrest.
Isoda M; Kanemori Y; Nakajo N; Uchida S; Yamashita K; Ueno H; Sagata N
Mol Biol Cell; 2009 Apr; 20(8):2186-95. PubMed ID: 19244340
[TBL] [Abstract][Full Text] [Related]
50. Reactivation of silenced α-N-catenin induces retinoic acid sensitivity in neuroblastoma cells.
Clark RA; Newton M; Qiao J; Lee S; Chung DH
Surgery; 2021 Nov; 170(5):1546-1553. PubMed ID: 34092372
[TBL] [Abstract][Full Text] [Related]
51. Morphologic conversion of a neuroblastoma-derived cell line by E6-mediated p53 degradation.
Gaitonde SV; Qi W; Falsey RR; Sidell N; Martinez JD
Cell Growth Differ; 2001 Jan; 12(1):19-27. PubMed ID: 11205742
[TBL] [Abstract][Full Text] [Related]
52. BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.
Coyaud E; Mis M; Laurent EM; Dunham WH; Couzens AL; Robitaille M; Gingras AC; Angers S; Raught B
Mol Cell Proteomics; 2015 Jul; 14(7):1781-95. PubMed ID: 25900982
[TBL] [Abstract][Full Text] [Related]
53. Modulation of SCF beta-TrCP-dependent I kappaB alpha ubiquitination by hydrogen peroxide.
Banerjee S; Zmijewski JW; Lorne E; Liu G; Sha Y; Abraham E
J Biol Chem; 2010 Jan; 285(4):2665-75. PubMed ID: 19933270
[TBL] [Abstract][Full Text] [Related]
54. DEPTOR ubiquitination and destruction by SCF(β-TrCP).
Wang Z; Zhong J; Gao D; Inuzuka H; Liu P; Wei W
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E163-9. PubMed ID: 22454292
[TBL] [Abstract][Full Text] [Related]
55. Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCF(FWD1/beta-TrCP)-mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1.
Hayakawa M; Matsushima M; Hagiwara H; Oshima T; Fujino T; Ando K; Kikugawa K; Tanaka H; Miyazawa K; Kitagawa M
Genes Cells; 2008 Apr; 13(4):329-42. PubMed ID: 18363964
[TBL] [Abstract][Full Text] [Related]
56. All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2.
Alique M; Herrero JF; Lucio-Cazana FJ
J Neuroinflammation; 2007 Jan; 4():1. PubMed ID: 17204142
[TBL] [Abstract][Full Text] [Related]
57. SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein.
Shirogane T; Jin J; Ang XL; Harper JW
J Biol Chem; 2005 Jul; 280(29):26863-72. PubMed ID: 15917222
[TBL] [Abstract][Full Text] [Related]
58. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
59. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
[TBL] [Abstract][Full Text] [Related]
60. Retinoic acid-induced differentiation of a human neuroblastoma cell line alters muscarinic receptor expression.
Baumgartner MK; Wei J; Aronstam RS
Brain Res Dev Brain Res; 1993 Apr; 72(2):305-8. PubMed ID: 8485852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]